Skip to main content

pSBbi-moxGFP-P2A-T2A-cMyc-Puro Citations (1)

Originally described in: MYC dosage compensation is mediated by miRNA-transcription factor interactions in aneuploid cancer.
Acon M, Geiss C, Torres-Calvo J, Bravo-Estupinan D, Oviedo G, Arias-Arias JL, Rojas-Matey LA, Edwin B, Vasquez-Vargas G, Oses-Vargas Y, Guevara-Coto J, Segura-Castillo A, Siles-Canales F, Quiros-Barrantes S, Regnier-Vigouroux A, Mendes P, Mora-Rodriguez R iScience. 2021 Nov 8;24(12):103407. doi: 10.1016/j.isci.2021.103407. eCollection 2021 Dec 17.
PubMed Journal

Articles Citing pSBbi-moxGFP-P2A-T2A-cMyc-Puro

Articles
A Synthetic Sponge System Against miRNAs of the miR-17/92 Cluster Targets Transcriptional MYC Dosage Compensation in Aneuploid Cancer. Bravo-Estupinan DM, Geiss C, Arias-Arias JL, Montano-Samaniego M, Chinchilla-Monge R, Marin-Muller C, Quiros-Barrantes S, Regnier-Vigouroux A, Ibanez-Hernandez M, Mora-Rodriguez RA. Cells. 2025 Sep 4;14(17):1384. doi: 10.3390/cells14171384. PubMed

If you have published an article using this material, please email us at [email protected] to have your article added to this page.